TARGET PharmaSolutions announced this week they have entered into a long term collaboration with Novartis. The new multi year partnership will involve collaboration on the NASH study, focused on patients with nonalcoholic fatty liver disease or nonalcoholic steatohepatitis.
https://www.bizjournals.com/triangle/news/2018/01/10/novartis-becomes-latest-big-name-collaborator-for.html
